On one hand, activation of the AKT pathway and nuclear β-catenin accumulation has been reported in human synovial sarcoma tissues [23, 24, 32], showing a trend towards poorer survival in those patients with nuclear β-catenin [32, 33]. The gene discussed is AKT1; the disease is synovial sarcoma.